US team develops prognostic gene chip for neuroblastoma:
This article was originally published in Clinica
US researchers have developed a DNA chip that could help predict outcomes for infants with neuroblastoma, a common form of cancer in children less than 10 years of age. The chip can be configured to identify selected genetic abnormalities and deletions in isolated regions of chromosome 11, which is believed to allow aggressive neuroblastoma to take hold. Investigators from The Children's Hospital of Philadelphia and Thomas Jefferson University said that the chip could also be modified to help identify other forms of cancer. Their proof-of-principle study featured in the August edition of Genome Research. The team is currently seeking industry support to help improve the technology.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.